Log in
Enquire now
‌

US Patent 10138472 Engineered nucleic-acid targeting nucleic acids

Patent 10138472 was granted and assigned to Caribou Biosciences on November, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Caribou Biosciences
Caribou Biosciences
0
Current Assignee
Caribou Biosciences
Caribou Biosciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
101384720
Patent Inventor Names
Andrew Paul May0
Paul Daniel Donohoue0
Date of Patent
November 27, 2018
0
Patent Application Number
160365990
Date Filed
July 16, 2018
0
Patent Citations Received
‌
US Patent 11866726 Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
0
Patent Primary Examiner
‌
Delia M. Ramirez
0
Patent abstract

The present disclosure provides engineered cross-type-nucleic-acid targeting nucleic acids and compositions thereof. Nucleic acid sequences encoding the engineered cross-type-nucleic-acid targeting nucleic acids, as well as expression cassettes, vectors and cells comprising such nucleic acid sequences, are described. Also, methods are disclosed for making and using the engineered cross-type-nucleic-acid targeting nucleic acids and compositions thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10138472 Engineered nucleic-acid targeting nucleic acids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.